2017 A/H7N9 IIV Revaccination
Clinical trial NCT03738241 · COMPLETED
Trial details
- NCT number
- NCT03738241
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2020-06-19
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.